-
Je něco špatně v tomto záznamu ?
Gastric pH in rats: Key determinant for preclinical evaluation of pH-dependent oral drug absorption
M. Šíma, N. Kutinová-Canová, P. Ryšánek, J. Hořínková, D. Moškořová, O. Slanař
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Grantová podpora
Progres Q25
Univerzita Karlova v Praze
SVV 260373
Univerzita Karlova v Praze
NLK
Directory of Open Access Journals
od 2012
Medline Complete (EBSCOhost)
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- MeSH
- inhibitory protonové pumpy * farmakokinetika MeSH
- koncentrace vodíkových iontů MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- modely u zvířat MeSH
- náhodné rozdělení MeSH
- omeprazol * farmakokinetika MeSH
- potkani Wistar MeSH
- žaludeční sliznice * MeSH
- žaludek * chemie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Data on gastric pH in rats to be used in preclinical models for pH-dependent drug absorption are still limited or contradictory. The aim of this study was to describe gastric pH in rats at fasted state and to evaluate its changes induced by pentagastrin or omeprazole in order to mimic gastric pH at fasted and fed human subjects. Twenty Wistar rats, fasting for 12 h, were randomly assigned into four treatment groups (n=5): control, pre-treated with omeprazole 2 h before pH measurement, pre-treated with omeprazole 12 h before pH measurement, and pre-treated with pentagastrin 20 min before pH measurement. An incision on the stomach wall was made in anesthetized animals, and pH of gastric juice was measured. The observed pH values were significantly different among groups (p=0.0341), with the median (IQR) values of gastric pH of 3.5 (2.7-4.2), 6.7 (4.7-7.0), 5.6 (3.5-6.4) and 2.2 (1.6-3.1) in control, omeprazole 2 h, omeprazole 12 h and pentagastin group, respectively. We recommend using short interval pentagastrin and 2 h omeprazole pre-treatment in fasting animals to model similar gastric pH as is expected in human fasted and fed state pharmacokinetic studies, respectively.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19021890
- 003
- CZ-PrNML
- 005
- 20190805142512.0
- 007
- ta
- 008
- 190607s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/23362936.2019.5 $2 doi
- 035 __
- $a (PubMed)31103048
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šíma, Martin $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0222901
- 245 10
- $a Gastric pH in rats: Key determinant for preclinical evaluation of pH-dependent oral drug absorption / $c M. Šíma, N. Kutinová-Canová, P. Ryšánek, J. Hořínková, D. Moškořová, O. Slanař
- 520 9_
- $a Data on gastric pH in rats to be used in preclinical models for pH-dependent drug absorption are still limited or contradictory. The aim of this study was to describe gastric pH in rats at fasted state and to evaluate its changes induced by pentagastrin or omeprazole in order to mimic gastric pH at fasted and fed human subjects. Twenty Wistar rats, fasting for 12 h, were randomly assigned into four treatment groups (n=5): control, pre-treated with omeprazole 2 h before pH measurement, pre-treated with omeprazole 12 h before pH measurement, and pre-treated with pentagastrin 20 min before pH measurement. An incision on the stomach wall was made in anesthetized animals, and pH of gastric juice was measured. The observed pH values were significantly different among groups (p=0.0341), with the median (IQR) values of gastric pH of 3.5 (2.7-4.2), 6.7 (4.7-7.0), 5.6 (3.5-6.4) and 2.2 (1.6-3.1) in control, omeprazole 2 h, omeprazole 12 h and pentagastin group, respectively. We recommend using short interval pentagastrin and 2 h omeprazole pre-treatment in fasting animals to model similar gastric pH as is expected in human fasted and fed state pharmacokinetic studies, respectively.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a žaludeční sliznice $7 D005753
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a modely u zvířat $7 D023421
- 650 12
- $a omeprazol $x farmakokinetika $7 D009853
- 650 12
- $a inhibitory protonové pumpy $x farmakokinetika $7 D054328
- 650 _2
- $a náhodné rozdělení $7 D011897
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 12
- $a žaludek $x chemie $7 D013270
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kutinová-Canová, Nikolína $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0103768
- 700 1_
- $a Ryšánek, Pavel $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0239090
- 700 1_
- $a Hořínková, Jana $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0228030
- 700 1_
- $a Moškořová, Denisa $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0239091
- 700 1_
- $a Slanař, Ondřej $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0058262
- 773 0_
- $w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 120, č. 1 (2019), s. 5-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31103048 $y Pubmed
- 856 41
- $u https://pmr.lf1.cuni.cz/media/pdf/pmr_2019120010005.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 7 $c 1071 $y 4 $z 0
- 990 __
- $a 20190607 $b ABA008
- 991 __
- $a 20190805142635 $b ABA008
- 999 __
- $a ok $b bmc $g 1429470 $s 1060245
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 120 $c 1 $d 5-9 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
- GRA __
- $a Progres Q25 $p Univerzita Karlova v Praze
- GRA __
- $a SVV 260373 $p Univerzita Karlova v Praze
- LZP __
- $b NLK111 $a Pubmed-20190607